European Pharmaceutical Review

JUNE 10, 2024

The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. The company hopes to produce this number tenfold by the end of 2030.

Manufacturing 98

Manufacturing Distribution Pharmaceutical manufacturing Leads 98

European Pharmaceutical Review

NOVEMBER 10, 2023

The construction projects will be finalised from the end of 2025 through to 2029. Novo Nordisk’s Denmark manufacturing facilities Currently, Novo Nordisk’s Kalundborg production facilities manufacture products for treating obesity and diabetes as well as several biopharmaceutical products, employing around 4,400 employees.

Manufacturing 111

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 111

European Pharmaceutical Review

AUGUST 17, 2022

Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. The WuXi STA Middletown facility is expected to begin operations in 2025.

Manufacturing 96

Manufacturing Pharmaceutical manufacturing Distribution Pharmaceutical 96

European Pharmaceutical Review

SEPTEMBER 14, 2023

Once operational in early 2025, the partnership will reduce emissions by an estimated 20,000 tonnes CO 2 equivalent (CO 2 e). Alongside this move, AstraZeneca’s investment in major energy efficiencies in its operations, brings the total of its financial commitment to net zero, to £100 million.

Manufacturing 111

Manufacturing Medicine Pharmaceutical manufacturing Pharma 111

European Pharmaceutical Review

JULY 24, 2024

With the opening of the new facility, “hundreds” of high-tech jobs will be established at the site by the end of 2025, according to BeiGene. The site in Hopewell features approximately 400,000 ft 2 for commercial-stage biologic pharmaceutical manufacturing capacity.

Manufacturing 52

Manufacturing Pharmaceutical manufacturing Medicine Pharmaceutical 52

European Pharmaceutical Review

SEPTEMBER 26, 2022

AbbVie , an international R&D biopharmaceutical enterprise has celebrated its 20th anniversary by investing in extensive renovations at its manufacturing site in Cork, Ireland. The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

European Pharmaceutical Review

SEPTEMBER 28, 2023

A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.

Manufacturing 98

Manufacturing Government Pharmaceutical manufacturing Pharmaceutical 98